Form D · Biotechnology
Kayak Therapeutics, Inc.
Austin, TX · CIK 0002088831
Offering snapshot reported Aug 21, 2026 · SEC filing
- Reported sold
- $25M Offering amount: $30M
- Investors reported
- 137 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 12, 2026 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$11,940,000 → $24,981,000
- Reported investors55 → 137
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2026 | Amendment | $24,981,000 | $13,041,000vs May 27, 2026 | 137 | SEC filing |
| May 27, 2026 | Initial | $11,940,000 | No comparison | 55 | SEC filing |
| Sep 29, 2025 | Initial | $6,630,000 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-585230
Source: Form D, filed Aug 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tyler Brous | Director |
| Josiah Hornblower | Director, Executive |
| Hornblower Josiah | Director, Executive |
| Conor Richardson | Executive |
| Taylor Schreiber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Austin, TX, 78703
Phone: 917.892.9996